mRNA COVID Vaccine Dosing Intervals May Be Extended To Mitigate Myocarditis Risk

 
• By Brenda Sandburg
  
Spikevax and Comirnaty
CDC advisory committee considers myocarditis risk with Moderna and Pfizer's mRNA vaccines • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Archive

More from Pink Sheet